Infant Mortality Rates Vary Across Race, Hispanic-Origin Groups
By Elana Gotkine HealthDay Reporter
TUESDAY, March 5, 2024 -- There is variation in infant mortality rates across maternal race and Hispanic-origin groups and by selected maternal characteristics, according to the March 5 National Vital Statistics Reports, a publication from the National Center for Health Statistics.
Danielle M. Ely, Ph.D., and Anne K. Driscoll, Ph.D., from the National Center for Health Statistics in Hyattsville, Maryland, present infant mortality rates for selected maternal characteristics for the five largest maternal race and Hispanic-origin groups in the United States for 2019 to 2021.
The researchers noted variation in infant mortality rates across the five largest maternal race and Hispanic-origin groups and by selected maternal characteristics. Mortality rates were higher for infants of mothers with prepregnancy obesity versus those with normal weight among most race and Hispanic-origin groups; rates were also higher for infants of women who smoked cigarettes during pregnancy and who received late or no prenatal care and for those covered by Medicaid as the source of payment for delivery. Infants of women who received Special Supplemental Nutrition Program for Women, Infants, and Children benefits had higher mortality rates, with variation noted across race and Hispanic-origin groups. For the maternal characteristics examined, mortality rates were generally highest among infants of Black non-Hispanic and American Indian and Alaska Native non-Hispanic women and were lowest for Asian non-Hispanic women.
"These findings demonstrate the importance of examining infant mortality by detailed race and Hispanic origin whenever possible to better focus efforts to improve infant outcomes," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted March 2024
Read this next
AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours
WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million
TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...
Patient–Primary Care Provider Language Concordance Tied to Better Outcomes
TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.